Bringing the fundamentals into focus…
Back to Veradermics, Incorporated
How Veradermics, Incorporated stacks up
MANE · against 219 other Healthcare companies of similar size
Profitability
25/ 100
Near the bottom of its peers.
Ranked #176 of 220 · scores higher than 20% of peers
Bars: peers in each 10-point band of the profitability score25 peers with a profitability score of 20–29, including MANE · Click a bar to see the companies
Why profitability scores 25?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 77% of peers. Return on invested capital: -16.4% vs peer median 4.7%
- a lower return on assets: weaker than 76% of peers. Return on assets: -11.2% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = MANE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MANE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 212 reported | -16.4% | 8.2% | 20% | 33% | |
| Operating marginHigher is better · 200 reported | Not reported | 10.7% | — | — | 33% |
| Return on assetsHigher is better · 210 reported | -11.2% | 3.3% | 21% | 33% | |
| Return on equityHigher is better · 205 reported | Not reported | 7.7% | — | — | Context only |
| Gross marginHigher is better · 229 reported | 0.0% | 49.5% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around MANE| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 5 | 548.2B INR (≈$6.6B) | 98 | 68 | |
| 172 | 3.3B USD | 26 | 44 | |
| 172 | 6.6B USD | 26 | 45 | |
| 172 | 8.5B USD | 26 | 28 | |
| 176 | 4.1B USD | 25 | 39 | |
| 176 | 5.6B USD | 25 | 53 | |
| 178 | 8.8B USD | 24 | 50 | |
| 179 | 4.2B USD | 23 | 44 | |
| 179 | 9.0B USD | 23 | 33 | |
| 181 | 34.9B CNY (≈$4.9B) | 22 | 16 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score